These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19589624)

  • 21. 4,5-dihydropyridazin-3-one derivatives as histamine H₃ receptor inverse agonists.
    Hudkins RL; Aimone LD; Dandu RR; Dunn D; Gruner JA; Huang Z; Josef KA; Lyons JA; Mathiasen JR; Tao M; Zulli AL; Raddatz R
    Bioorg Med Chem Lett; 2012 Jan; 22(1):194-8. PubMed ID: 22142542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.
    Crespo A; Meyers C; Coelho A; Yáñez M; Fraiz N; Sotelo E; Maes BU; Laguna R; Cano E; Lemière GL; Raviña E
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1080-3. PubMed ID: 16290144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasodilatory activity of novel carbamate derivatives of isatin.
    Maroñas PA; Sudo RT; Corrêa MB; Pinto AC; Garden SJ; Trachez MM; Zapata-Sudo G
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1091-6. PubMed ID: 18505449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triazole incorporated pyridazinones as a new class of antihypertensive agents: design, synthesis and in vivo screening.
    Siddiqui AA; Mishra R; Shaharyar M; Husain A; Rashid M; Pal P
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1023-6. PubMed ID: 21211966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of some new pyridazinone derivatives.
    Husain A; Drabu S; Kumar N; Alam MM; Ahmad A
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):742-8. PubMed ID: 21271866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and SAR of pyridazinone-substituted phenylalanine amide alpha4 integrin antagonists.
    Gong Y; Kent Barbay J; Kimball ES; Santulli RJ; Carolyn Fisher M; Dyatkin AB; Miskowski TA; Hornby PJ; He W
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1331-5. PubMed ID: 18226905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological activity of the four stereoisomers of 6-[4-[3-[[2-hydroxy-3-[4-[2- (cyclopropylmethoxy)ethyl]phenoxy]propyl]amino]-propionamido] phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone, a combined vasodilator and beta-adrenoceptor antagonist.
    Howson W; Kitteringham J; Mistry J; Mitchell MB; Novelli R; Slater RA; Swayne GT
    J Med Chem; 1988 Feb; 31(2):352-6. PubMed ID: 2892935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure.
    Sircar I; Steffen RP; Bobowski G; Burke SE; Newton RS; Weishaar RE; Bristol JA; Evans DB
    J Med Chem; 1989 Feb; 32(2):342-50. PubMed ID: 2536438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New amido derivatives as potential BKCa potassium channel activators. XI.
    Calderone V; Fiamingo FL; Amato G; Giorgi I; Livi O; Martelli A; Martinotti E
    Eur J Med Chem; 2008 Apr; 43(4):792-9. PubMed ID: 17692999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
    Meyers C; Yáñez M; Elmaatougi A; Verhelst T; Coelho A; Fraiz N; Lemière GL; García-Mera X; Laguna R; Cano E; Maes BU; Sotelo E
    Bioorg Med Chem Lett; 2008 Jan; 18(2):793-7. PubMed ID: 18053717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
    Slater RA; Howson W; Swayne GT; Taylor EM; Reavill DR
    J Med Chem; 1988 Feb; 31(2):345-51. PubMed ID: 2892934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, vasorelaxant activity and antihypertensive effect of benzo[d]imidazole derivatives.
    Navarrete-Vázquez G; Hidalgo-Figueroa S; Torres-Piedra M; Vergara-Galicia J; Rivera-Leyva JC; Estrada-Soto S; León-Rivera I; Aguilar-Guardarrama B; Rios-Gómez Y; Villalobos-Molina R; Ibarra-Barajas M
    Bioorg Med Chem; 2010 Jun; 18(11):3985-91. PubMed ID: 20451399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New, simple and versatile synthesis of 4,6-disubstituted pyridazin-3(2H)-ones.
    Albrecht A; Koszuk J; Kobuciński M; Janecki T
    Org Biomol Chem; 2008 Apr; 6(7):1197-200. PubMed ID: 18362958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on pyridazinone derivatives. XVI. Analgesic-antiinflammatory activities of 3(2H)-pyridazinone derivatives].
    Takaya M; Sato M
    Yakugaku Zasshi; 1994 Feb; 114(2):94-110. PubMed ID: 8169774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and pharmacological evaluation of some N-arylsulfonyl-N-methyl-N'-(2,2-dimethyl-2H-1-benzopyran-4-yl)ureas structurally related to cromakalim.
    Khelili S; Lebrun P; de Tullio P; Pirotte B
    Bioorg Med Chem; 2006 May; 14(10):3530-4. PubMed ID: 16455262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synthesis and vasorelaxant activities of benzopyran-4-one hydrazone derivatives].
    Zhao SY; Huang WL; Zhang HB
    Yao Xue Xue Bao; 2002 Aug; 37(8):621-5. PubMed ID: 12567776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on agents with vasodilator and beta-blocking activities. I.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigations of new pyridazinone derivatives for the synthesis of potent analgesic and anti-inflammatory compounds with cyclooxygenase inhibitory activity.
    Okçelik B; Unlü S; Banoglu E; Küpeli E; Yeşilada E; Sahin MF
    Arch Pharm (Weinheim); 2003 Sep; 336(9):406-12. PubMed ID: 14528488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigations on the synthesis and properties of some N-arylpiperazinylalkyl derivatives of 1,4-dioxo (1,4,5-trioxo)-1,2,3,4-tetra (and 1,2,3,4,5,6-hexa)hydropyrido[3,4-d]pyridazines.
    Sladowska H; Potoczek J; Sieklucka-Dziuba M; Rajtar G; Møynarczyk M; Kleinrok Z
    Farmaco; 1995 Jan; 50(1):37-46. PubMed ID: 7702719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
    Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
    Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.